<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04267341</url>
  </required_header>
  <id_info>
    <org_study_id>2019/24-01</org_study_id>
    <nct_id>NCT04267341</nct_id>
  </id_info>
  <brief_title>Effect of Dual Task on Upper and Lower Extremity Skills in Parkinson's Disease</brief_title>
  <official_title>Examining The Change of Upper and Lower Extremity Skills With The Effect of Dual Task in Parkinson's Disease Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hacettepe University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hacettepe University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate the change of lower and upper extremity skills with
      dual task in Parkinson's disease patients and to determine the differences between
      Parkinson's disease patients with different stages of disease and the healthy controls
      regarding the change of lower and upper extremity skills with dual task.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2020</completion_date>
  <primary_completion_date type="Actual">March 15, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Timed Up and Go Test</measure>
    <time_frame>10-15 seconds</time_frame>
    <description>Functional mobility is assessed by using the timed up and go test. The timed up and go test measures the time that a patient needs to stand up from a chair, walk a 3-m distance, come back and sit back on the chair.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>10 Meter Walk Test</measure>
    <time_frame>10-15 seconds</time_frame>
    <description>10 Meter Walk Test measures the time required to complete straight walk of 10 meters distance.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Purdue Pegboard Test</measure>
    <time_frame>3-5 minutes</time_frame>
    <description>Purdue Pegboard Test assesses the speed and motor dexterity of each hand and the manual dexterity using both hands at the same time. The PPT consists of a board with two columns with 25 holes each and a specific number of pins, washers and collars placed in four containers across the top of the board.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Modified Hoehn and Yahr Scale</measure>
    <time_frame>1 minute</time_frame>
    <description>Modified Hoehn and Yahr Scale allocates stages from 0 to 5 to indicate the relative level of disability and stage of disease. Higher level indicates worse physical condition.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Montreal Cognitive Assessment (MoCA)</measure>
    <time_frame>10-15 minutes</time_frame>
    <description>Montreal Cognitive Assessment (MoCA) will be used in order to evaluate cognition. It assesses different cognitive domains: attention and concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation.It' score ranged from 0 to 30 and higher points indicates better cognitive outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short-Form 8-Item Parkinson's Disease Questionnaire (PDQ-8)</measure>
    <time_frame>1-2 minutes</time_frame>
    <description>The short-form 8-item Parkinson's disease Questionnaire (PDQ-8) is the most commonly used scale measuring health related quality of life (HRQoL) in PD patients. It includes 8 items, and each item has five options (never, occasionally, sometimes, often, always or cannot do at all). The total score ranges from 0 to 32. Higher scores indicates poorer quality of life.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Parkinson Disease</condition>
  <condition>Movement Disorders</condition>
  <arm_group>
    <arm_group_label>Mild Stage Parkinson's Disease Patients</arm_group_label>
    <description>Modified Hoehn and Yahr stage 1-2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate Stage Parkinson's Disease Patients</arm_group_label>
    <description>Modified Hoehn and Yahr stage 2.5-3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Control</arm_group_label>
    <description>Healthy People</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Timed Up and Go Test</intervention_name>
    <description>It requires individual to stand up from an armed chair, walk 3m, turn around, walk back to the armed chair, and sit down again</description>
    <arm_group_label>Healthy Control</arm_group_label>
    <arm_group_label>Mild Stage Parkinson's Disease Patients</arm_group_label>
    <arm_group_label>Moderate Stage Parkinson's Disease Patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>10 Meter Walk Test</intervention_name>
    <description>10 Meter Walk Test measures the time required to complete straight walk of 10 meters distance</description>
    <arm_group_label>Healthy Control</arm_group_label>
    <arm_group_label>Mild Stage Parkinson's Disease Patients</arm_group_label>
    <arm_group_label>Moderate Stage Parkinson's Disease Patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Purdue Pegboard Test</intervention_name>
    <description>Purdue Pegboard test evaluates the fine manuel dexterity</description>
    <arm_group_label>Healthy Control</arm_group_label>
    <arm_group_label>Mild Stage Parkinson's Disease Patients</arm_group_label>
    <arm_group_label>Moderate Stage Parkinson's Disease Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Parkinson's Disease who apply to the Hacettepe University, Faculty of
        Physiotherapy and Rehabilitation, Department of Neurological Rehabilitation will be invited
        to this study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Modified Hoehn &amp; Yahr (H&amp;Y) stages 1 to 3

          -  at least 40 years of age

          -  21 or more MoCA score.

        Exclusion Criteria:

          -  other neurologic disorder

          -  any orthopedic problem that could prevent to participate in the study

          -  severe dyskinesia or tremor

          -  visual or speech problems
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hacettepe University, Faculty of Physical Therapy and Rehabilitation</name>
      <address>
        <city>Ankara</city>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>February 11, 2020</study_first_submitted>
  <study_first_submitted_qc>February 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2020</study_first_posted>
  <last_update_submitted>May 3, 2020</last_update_submitted>
  <last_update_submitted_qc>May 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hacettepe University</investigator_affiliation>
    <investigator_full_name>Elvan ÖZCAN GÜLŞEN</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Movement Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

